Neuromuscular-Blocking Agents (Nondepolarizing)

All categories
DBCAT002684Therapeutic category

Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive... A DrugBank category of 16 drugs. 14 of them are approved.

Part of
Neuromuscular Blocking Agents
Also known as
Agents, Curare-Like · Agents, Neuromuscular Nondepolarizing · Blockers, Nondepolarizing · Curare Like Agents · Curare-Like Agents
Drugs

What you can answer from here — as of September 25, 2018

16DrugsEach linked to its full drug card
Listed above
15Drug targetsEvery drug–target pair in the class, with bond type
Sign in
636Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
6Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Neuromuscular-Blocking Agents (Nondepolarizing) share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In